Related Experiment Video
Updated: Apr 29, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.8K
Antitumor immunity induced after α irradiation
Jean-Baptiste Gorin1, Jérémie Ménager1, Sébastien Gouard1
1CRCNA-UMR 892 INSERM, Nantes, France; CNRS, Nantes, France; University of Nantes, Nantes, France.
Neoplasia (New York, N.Y.)
|May 28, 2014
Summary
Alpha particle radioimmunotherapy (RIT) using bismuth-213 shows promise in cancer treatment. This study reveals that alpha irradiation stimulates adaptive immunity and provides antitumor protection by inducing immunogenic cell death.
Area of Science:
- Oncology
- Immunology
- Radiochemistry
Background:
- Radioimmunotherapy (RIT) traditionally uses beta emitters, but alpha emitters are gaining interest for targeted cancer cell killing.
- Alpha particles offer high linear energy transfer and a short path, making them effective against small tumor clusters.
- Previous research focused on alpha emitter radiobiology, but their impact on the immune system remained unexplored.
Purpose of the Study:
- To investigate the immunogenicity of murine adenocarcinoma MC-38 cells following alpha irradiation with bismuth-213 ((213)Bi).
- To evaluate the potential of alpha irradiation to stimulate an antitumor immune response.
- To explore the molecular mechanisms underlying alpha particle-induced immune activation.
Main Methods:
- Murine adenocarcinoma MC-38 cells were irradiated with (213)Bi.
- In vivo studies were conducted using immunocompetent C57Bl/6 mice.
- In vitro studies analyzed molecular mechanisms of immune activation, including "danger signals" and dendritic cell activation.
Main Results:
- In vivo studies demonstrated a protective antitumor response mediated by tumor-specific T cells in mice.
- In vitro studies showed that (213)Bi-treated MC-38 cells released "danger signals".
- (213)Bi-treated cells activated dendritic cells, suggesting a role in initiating adaptive immunity.
Conclusions:
- Alpha irradiation with (213)Bi stimulates adaptive immunity.
- This alpha emitter elicits an efficient antitumor protection, acting as an immunogenic cell death inducer.
- Alpha irradiation offers a promising complement to direct tumor cell killing in cancer therapy.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:27Cytotoxic T Cells-mediated Immune Response
7.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K